2018 Clinical Chemistry and Immunodiagnostic POC and Laboratory Instrumentation, and Strategic Profiles of Leading Suppliers

LONDON, Dec. 10, 2018 /PRNewswire/ -- 2018 Clinical Chemistry and Immunodiagnostic POC and Laboratory Instrumentation, and Strategic Profiles of Leading Suppliers

Download the full report: https://www.reportbuyer.com/product/5643986

This 68-page report reviews operating characteristics and features of high-, medium-, and low-volume/POC clinical chemistry and immunodiagnostic systems.

Download the full report: https://www.reportbuyer.com/product/5643986 About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: [email protected] Tel: +1 (718) 213 4904 Website: www.reportbuyer.com

View original content:http://www.prnewswire.com/news-releases/2018-clinical-chemistry-and-immunodiagnostic-poc-and-laboratory-instrumentation-and-strategic-profiles-of-leading-suppliers-300762701.html

SOURCE ReportBuyer

Latest Press Release on General News

Nicklaus Children's Health System, Philips to Provide Innovative Patient and Staff Experience, Helping to Enhance Outcomes for the Smallest of Patients

April 30, 2024 Philips AI-enabled diagnostic and experiential technologies help put patients at ease while empowering staff with faster, high-quality scans and increased diagnostic c...

Cinesteam® Is a Deodorizing Support Tool for Palliative Care

Palliative Care Is a Comprehensive Approach to Long-Term Patient Care. Caregivers Can Use Cinesteam®'s Secondary Dressings to Improve Quality of Life in Palliative Care Settings. FOR...

Philips Delivers First-quarter Results in Line With 2024 Performance Improvement Plan; Resolves the Respironics Personal Injury and Medical Monitoring Litigation in the Us for USD 1.1 Billion

April 29, 2024 First-quarter highlights Group sales amounted to EUR 4.1 billion, with comparable sales growth of 2.4% Comparable order intake -3.8%, mainly due to China USD 1.1 b...

eNeura Achieves Record-Breaking Sales and Announces Notice of Allowance for a New Patent on Prophylactic Treatment of Migraine Headache

Record sales in April accelerating the pathway to profitability New IP will lead the way in changing the way migraine headaches are addressed WEST PALM BEACH, Fla. , April 26, ...

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...